Clopidogrel and similar prescription antiplatelet medications are typically prescribed for a specific cardiovascular reason, and already carry meaningful bleeding-risk monitoring. Adding trazodone's own modest platelet-related effect makes this combination worth flagging clearly to whichever prescriber manages the antiplatelet therapy.
Trazodone and clopidogrel (or other antiplatelet medications)
Prescription antiplatelet medications carry a more significant baseline bleeding-risk profile, making the additive effect of a serotonergic medication like trazodone more clinically relevant.
Editorially reviewed
Key points
- Baseline bleeding risk with these medications is already significant
- Adding trazodone is a modest, additive consideration
- Clearly flag this combination to your cardiology or primary care team
Not medical advice. Always tell your prescriber and pharmacist about every medication, supplement, and substance you use so they can check for interactions specific to your situation.